Document Detail

Serial Assessment of Coronary Artery Response to Paclitaxel-Eluting Stents Using Optical Coherence Tomography.
MedLine Citation:
PMID:  22298797     Owner:  NLM     Status:  Publisher    
BACKGROUND: The paucity of longitudinal, serial high-resolution imaging studies has limited our understanding of in vivo arterial response to drug-eluting stents. We sought to investigate the human coronary response to paclitaxel-eluting stent implantation, using serial optical coherence tomography assessments. METHODS AND RESULTS: Thirty patients with at least 2 significant coronary lesions in different vessels were treated with a paclitaxel-eluting stent. The most severe stenosis (lesion A) was treated at the initial procedure, and the second target vessel (lesion B) was stented 3 months later. Optical coherence tomography was performed at baseline, 3-, and 9-month follow-up for lesions A and baseline and 6 months for lesions B. Prespecified end points were percent of uncovered and malapposed struts over time. In lesions A, uncovered struts were 3.77±4.94% and 3.02±4.35% at 3 versus 9 months (P=NS). Malapposed struts were 3.55±5.16% at post-procedure, 1.51±3.52% at 3 months, and 0.60±1.82% at 9 months (P<0.05, at 3 versus 9 months). Strut-level neointimal thickness was 0.19±0.09 mm and 0.20±0.11 mm (P=NS) over time. Newly acquired malapposition was detected in 10.4% and 3.3% of 2.5-mm segments at 3- and 9-month follow-up. In lesions B, uncovered struts were 2.91±5.47% at 6-months. Malapposed struts were 4.94±6.70% post-procedure and 1.01±3.11% at 6 months (P<0.01), with 0.19±0.09-mm neointimal thickness at follow-up. CONCLUSIONS: Optical coherence tomography imaging suggested the first 3 months to be the period with most biological activity after paclitaxel-eluting stent implantation, when the proliferative reaction mainly occurs and malapposition resolves. A less active, yet continuous, dynamic arterial response, with resolution and development of malapposition, occurs through 9 months post-treatment. CLINICAL TRIAL REGISTRATION: URL: Unique identifier: NCT00704145.
Giulio Guagliumi; Hiram G Bezerra; Vasile Sirbu; Hideyuki Ikejima; Giuseppe Musumeci; Giuseppe Biondi-Zoccai; Nikoloz Lortkipanidze; Luigi Fiocca; Davide Capodanno; Wei Wang; Satoko Tahara; Angelina Vassileva; Aleksandre Matiashvili; Orazio Valsecchi; Marco A Costa
Related Documents :
23992557 - A randomized trial of colchicine for acute pericarditis.
9040577 - Extracorporeal support for intractable cardiorespiratory failure due to meningococcal d...
19857707 - Is there a difference between patients with peak oxygen consumption below 10 ml/kg/min ...
18812277 - Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly de...
21997197 - Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus tria...
25021507 - Pwe-027 the reasons for gender differences in caecal intubation rates - analysis of 8...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-31
Journal Detail:
Title:  Circulation. Cardiovascular interventions     Volume:  -     ISSN:  1941-7632     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-2-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101499602     Medline TA:  Circ Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Cardiovascular Department, Ospedali Riuniti, Bergamo, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fixation Temperature Affects DNA Integrity in the Testis as Measured by the TUNEL Assay.
Next Document:  No Association of ABCB1 C3435T Genotype With Clopidogrel Response or Risk of Stent Thrombosis in Pat...